These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25480587)

  • 21. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.
    Hollier BG; Tinnirello AA; Werden SJ; Evans KW; Taube JH; Sarkar TR; Sphyris N; Shariati M; Kumar SV; Battula VL; Herschkowitz JI; Guerra R; Chang JT; Miura N; Rosen JM; Mani SA
    Cancer Res; 2013 Mar; 73(6):1981-92. PubMed ID: 23378344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.
    Li W; Fu X; Liu R; Wu C; Bai J; Xu Y; Zhao Y; Xu Y
    Oncol Res; 2013; 21(2):111-20. PubMed ID: 24406047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
    Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
    Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression.
    Jiang W; Fan H; Qian C; Ding J; Wang Q; Pang X
    BMC Cancer; 2016 Jan; 16():16. PubMed ID: 26758745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.
    Yau C; Meyer L; Benz S; Vaske C; Scott G; Egan B; Labhart P; Pourmand N; Benz CC
    Breast Cancer Res Treat; 2015 Nov; 154(1):23-32. PubMed ID: 26456572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer.
    Feng YZ; Zhang QY; Fu MT; Zhang ZF; Wei M; Zhou JY; Shi R
    Oncol Rep; 2017 Jul; 38(1):109-119. PubMed ID: 28586040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship of c-FLIP(L) protein expression with molecular subtyping and clinical prognosis in invasive breast cancer].
    Zang F; Wei X; Sun B
    Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):442-6. PubMed ID: 25327791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of forkhead box C2 on carcinogenesis and lymphatic metastasis in endometrial carcinoma.
    Fan YY; Deng WG; Liu YN; Li YY; Deng SL; Fu Y
    Genet Mol Res; 2015 May; 14(2):5535-47. PubMed ID: 26125751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXC2 augments tumor propagation and metastasis in osteosarcoma.
    Gozo MC; Jia D; Aspuria PJ; Cheon DJ; Miura N; Walts AE; Karlan BY; Orsulic S
    Oncotarget; 2016 Oct; 7(42):68792-68802. PubMed ID: 27634875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
    Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
    Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer.
    Gozgit JM; Pentecost BT; Marconi SA; Otis CN; Wu C; Arcaro KF
    Mol Cancer Res; 2006 Dec; 4(12):905-13. PubMed ID: 17189381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
    Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
    Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role and the potential regulatory pathways of high expression of forkhead box C1 in promoting tumor growth and metastasis of basal-like breast cancer.
    Zuo HD; Wu Yao W
    J BUON; 2016; 21(4):818-825. PubMed ID: 27685901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA Let-7g Directly Targets Forkhead Box C2 (FOXC2) to Modulate Bone Metastasis in Breast Cancer.
    Wang L; Li M; Zhou Y; Zhao Y
    Open Med (Wars); 2017; 12():157-162. PubMed ID: 28894844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.
    Kang LJ; Yu ZH; Cai J; He R; Lu JT; Hou C; Wang QS; Li XQ; Zhang R; Feng YM
    FASEB J; 2019 May; 33(5):6564-6573. PubMed ID: 30807702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
    Lo PK; Lee JS; Liang X; Sukumar S
    Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.
    Sheffield BS; Kos Z; Asleh-Aburaya K; Wang XQ; Leung S; Gao D; Won J; Chow C; Rachamadugu R; Stijleman I; Wolber R; Gilks CB; Myles N; Thomson T; Hayes MM; Bernard PS; Nielsen TO; Chia SK
    Breast Cancer Res Treat; 2016 Feb; 155(3):483-90. PubMed ID: 26846986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
    Badowska-Kozakiewicz A; Sobol M; Patera J
    Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.